Pancreatic ductal adenocarcinoma (PDAC) is the fourth deadliest cancer and has a five-year survival rate of only 10 percent. PDAC, which accounts for more than 90 percent of pancreatic cancer cases, is known to be resistant to most therapeutic agents, and often the diagnosis is late in disease progression as symptoms are difficult to identify…. Read more »
Statewide Engagement
IUPUI researcher creates molecules with potential to treat COVID-19
Faculty and students at IUPUI are working on new ways to treat SARS-CoV-2, the virus causing COVID-19. Bill Scott, a research professor at the IUPUI School of Science, and his team have developed synthetic procedures to make numerous molecules to treat infections of both existing and mutated forms of SARS-CoV-2. The molecules created by Scott… Read more »
Moving IU innovation to market to improve Hoosier health
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed to the following story. In the last 30 years, Indiana University researcher Mark Kelley has disclosed 61 inventions, been awarded 19 patents, created a startup and licensed three of his technologies. He credits partnerships with IU’s Innovation and Commercialization Office (ICO) and… Read more »
IU School of Medicine researcher develops a novel, highly efficient method of producing retinal organoids
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. Current treatment options for degenerative retinal diseases are only temporary fixes. Degeneration of the retina can lead to partial loss of vision or complete blindness; however, a team of Indiana University researchers have found a method of developing retinal… Read more »
Strengthening civics education in Indiana and beyond
This week (March 6-10) marked the nation’s first-ever Civic Learning Week, which brought together students, educators, researchers, policymakers and other community members across the U.S. to reflect on ways to strengthen civics education. As distinguished former Indiana congressman Lee Hamilton opined this week, being a good citizen remains central to the functioning of the nation’s… Read more »
Building a reliable and sustainable home- and community-based services workforce
“Time waits for no man. The issues of the aging are the issues of us all.” On Thursday morning, March 9, Dr. Hannah Maxey, associate professor of family medicine and director of the Bowen Center for Health Workforce Research and Policy at the IU School of Medicine, opened with those words during her expert testimony… Read more »
Hoosier hoops great Alan Henderson set to bring his new venture game back to Bloomington
Alan Henderson will bring both his Indiana Basketball Hall of Fame stature and entrepreneurial prowess back to Bloomington this spring when he joins the best and brightest Indiana University innovators and investors from the Hoosier state and beyond at the annual IU Founders & Funders Network Venture Summit. The summit, hosted by IU Ventures, IU’s… Read more »
Driving a defense innovation ecosystem
Last week, Indiana University economic development leaders participated in a defense industry roundtable discussion with U.S. Sen. Todd Young. The event was hosted by the Crane Regional Defense Group at WestGate@Crane Technology Park. IU Vice President for University Relations Michael Huber and Joe Carley, IU director of economic development, were among 60 representatives from Indiana’s… Read more »
IU School of Medicine researcher develops non-invasive tool to detect mutations that could potentially lead to breast cancer
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. A non-invasive diagnostic test to detect mutations that could lead to early-stage breast cancer has been developed by Indiana University researcher Harikrishna Nakshatri, Marian J. Morrison Professor of Breast Cancer Research and professor of surgery, biochemistry and molecular biology… Read more »
IU School of Medicine researchers find RAP minimizes nephrotoxicity and acute kidney injury
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. Bruce Molitoris, MD, MS, a distinguished professor emeritus at the Indiana University School of Medicine and internationally acclaimed scientist, has determined that the Alpha-2-macroglubin Receptor Associated Protein, a naturally occurring protein inhibitor of kidney proximal tubule reabsorption, minimizes drug-induced… Read more »